Systematic analysis of gene expression pattern in has-miR-197 over-expressed human uterine leiomyoma cells.

Systematic analysis of gene expression pattern in has-miR-197 over-expressed human uterine leiomyoma cells.
复制标题

系统分析 has-miR-197 过表达的人子宫肌瘤细胞中的基因表达模式。

DOI:
10.1016/j.biopha.2015.07.039
复制
发表时间:
2015-10
期刊:
Biomedicine & Pharmacotherapy
影响因子:
--
通讯作者:
Xu, Qing
Xu, Qing
中科院分区:
其他
文献类型:
--
作者:
Wu, Xiaoli;Fu, Ziyi;Tan, Jie;Xu, Qing

文献摘要

参考文献

相似文献

IntroductionOur previous study showed that the expression of miR-197 in leiomyoma was down-regulated compared with myometrium. Further, miR-197 has been identified to affect uterine leiomyoma cell proliferation, apoptosis, and metastasis ability, though the responsible molecular mechanism has not been well elucidated. In this study, we sought to determine the expression patterns of miR-197 targeted genes and to explore their potential functions, participating Pathways and the networks that are involved in the biological behavior of human uterine leiomyoma.MethodsAfter transfection of human uterine leiomyoma cells with miR-197, we confirmed the expression level of miR-197 using quantitative real-time PCR (qRT-PCR), and we detected the gene expression profiles after miR-197 over-expression through DNA microarray analysis. Further, we performed GO and Pathway analysis. The dominantly dys-regulated genes, which were up- or down-regulated by more than 10-fold, compared with parental cells, were confirmed using qRT-PCR technology.ResultCompared with the control group, miR-197 was up-regulated by 30-fold after miR-197 lentiviral transfection. The microarray data showed that 872 genes were dys-regulated by more than 2-fold in human uterine leiomyoma cells after miR-197 overexpression, including 537 up-regulated and 335 down-regulated genes. The GO analysis indicated that the dys-regulated genes were primarily involved in response to stimuli, multicellular organ processes, and the signaling of biological progression. Further, Pathway analysis data showed that these genes participated in regulating several signaling Pathways, including the JAK/STAT signaling Pathway, the Toll-like receptor signaling Pathway, and cytokine–cytokine receptor interaction. The qRT-PCR results confirmed that 17 of the 66 selected genes, which were up- or down-regulated more than 10-fold by miR-197, were consistent with the microarray results, including tumorigenesis-related genes, such as DRT7, SLC549, SFMBT2, FLJ37956, FBLN2, C10orf35, HOXD12, CACNG7, and LOC100134279.ConclusionOur study explored gene expression patterns after miR-197 overexpression and confirmed 17 dominantly dys-regulated genes, which could expand the insights into the function of miR-197 and the molecular mechanisms during the development and progression of uterine leiomyomas. This study might afford new clues for understanding the pathogenesis of uterine leiomyomas, and it could likely provide a unique method for diagnosing or predicting prognosis in the clinical treatment of leiomyoma.
人子宫平滑肌瘤中 MicroRNA 及其靶基因产物的谱分析和功能分析
DOI: 10.1371/journal.pone.0012362
发表时间: 2010-08-24
期刊: PloS one
影响因子: 3.7
作者:
Zavadil J;Ye H;Liu Z;Wu J;Lee P;Hernando E;Soteropoulos P;Toruner GA;Wei JJ
通讯作者: Wei JJ
DOI: 10.1111/j.1582-4934.2007.00207.x
发表时间: 2008-01
影响因子: 5.3
作者:
Pan Q;Luo X;Chegini N
通讯作者: Chegini N
DOI: 10.1016/j.cancergencyto.2010.08.005
发表时间: 2010-12
影响因子: --
作者:
Maliheh Hashemi Nezhad;N. Drieschner;Sabrina Helms;Anke Meyer;Mahboobeh Tadayyon;Markus Klemke;G. Belge;S. Bartnitzke;K. Burchardt;C. Frantzen;E. H. Schmidt;J. Bullerdiek
通讯作者: Maliheh Hashemi Nezhad;N. Drieschner;Sabrina Helms;Anke Meyer;Mahboobeh Tadayyon;Markus Klemke;G. Belge;S. Bartnitzke;K. Burchardt;C. Frantzen;E. H. Schmidt;J. Bullerdiek
DOI: --
发表时间: 2011-08
影响因子: 1.4
作者:
D. Zheng;S. Haddadin;Yong Wang;L. Gu;M. Perry;C. Freter;Michael X. Wang
通讯作者: D. Zheng;S. Haddadin;Yong Wang;L. Gu;M. Perry;C. Freter;Michael X. Wang
DOI: 10.4161/cbt.10.4.12382
发表时间: 2010-08
影响因子: 3.6
作者:
H. J. Yun;S. Kim;Young-Yon Kwon;C. Kim;C. Kang;Eun Ju Kim
通讯作者: H. J. Yun;S. Kim;Young-Yon Kwon;C. Kim;C. Kang;Eun Ju Kim